GERMANTOWN, MD AND CHICAGO, IL / ACCESS Newswire / December 16, 2025 / uBriGene Biosciences, a leading global lentivirus CDMO specializing in Advanced Therapy Medicinal Product (ATMP) GMP development ...
The MarketWatch News Department was not involved in the creation of this content. GERMANTOWN, MD AND CHICAGO, IL / ACCESS Newswire / December 16, 2025 / uBriGene Biosciences, a leading global ...
LVV Turbo™ 293TH High-Productivity Suspension Cell Line Engineered for exceptional lentiviral productivity, the 293TH line consistently delivers high titers, producing up to five times higher ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback